Look at your feet. If the swelling includes your toes, that points to lymphoedema. If your legs are large and painful but your feet are a normal size, with a cuff-like cut-off at the ankle, that points to lipoedema. They are treated differently, so this is the first thing worth getting right. If your leg is hot, red and spreading and you feel unwell, that is an infection and it needs medical attention today, not at your next appointment. If one leg has suddenly swollen and it is painful, get assessed the same day. That can be a clot.
Think of the leg as a room with a tap and a drain. In lymphoedema the drain is blocked, so fluid backs up and eventually the walls themselves thicken, which is why a leg swollen for years never fully goes down again. Lipoedema is not a plumbing problem at all. The room was built with thicker walls, they are painful to press, and no amount of draining changes them.
Look at your feet.
If the swelling includes your toes, that points to lymphoedema. If your legs are large and painful but your feet are a normal size, with a cuff-like cut-off at the ankle, that points to lipoedema. The two are treated differently, so this is the first thing worth getting right.
The Verdict
Two conditions swell legs. Check the feet: lymphoedema takes the toes, lipoedema stops at the ankle.
Think of the leg as a room with a tap and a drain. In lymphoedema the drain is blocked, so fluid backs up, and given enough time the walls of the room thicken and stiffen too. That is why a leg swollen for years never fully goes down again, and why the treatment is pressure from outside rather than anything you can take. Lipoedema is not a plumbing problem at all. The room was built with thicker walls, they hurt when you press them, and draining a room that is not flooded changes nothing.
Anyone with long-standing leg swelling, or disproportionate and painful leg fat, who has never been given a clear diagnosis or a properly fitted compression garment.
Your swelling is new, in one leg and painful, your leg is hot and red, or nobody has checked your circulation. Those need assessment first, not compression.
Want the full evidence? Keep scrolling
Sustained compression, chosen for what the pressure will be tomorrow. Decongestion at a sustained 40 to 60 mmHg on the leg. An adjustable Velcro device at about 43 mmHg, re-tightened by the patient, outperformed an inelastic bandage started at about 63 mmHg: 26% versus 19% volume reduction at day 7, p<.001. The reason sits in the same trials. Bandage pressure fell from 63 to 22 mmHg within 48 hours, while a stocking held 33 to 26 and the readjusted device held its own. In genuine lower-limb lymphoedema over 15 sessions across 3 weeks, the device matched multilayer bandaging on volume and beat it on appearance, symptoms and quality of life.
Mosti 2015 (40 legs) · Mosti 2012 (42 legs) · Borman 2021 (36 patients, lower-limb lymphoedema). Expected timeline: measurable at 2 days, larger at 7, sustained at 1 month.
Above that, volume reduction decreases. Two independent groups locate the same turn in the curve, with a stated ceiling near 50 to 60 mmHg on the lower limb. Harder is not better, and a bandage that feels like more treatment can be doing less.
Partsch 2011 · Mosti 2012.
Preventive decongestive therapy after pelvic lymph node surgery. A bundle of drainage, compression hosiery, exercise and education for 12 months cut incidence from 34.5% to 13.6%, odds ratio 0.30 (95% CI 0.12 to 0.75), and delayed onset from 4.6 to 8.0 months. One single-centre trial, cervical-cancer population, unreplicated (Wang 2020).
Compression as the cellulitis-prevention intervention. Across 25 studies, lymphoedema management and particularly compression consistently reduced recurrence. That entire literature contains one randomised trial (Sierla 2026).
In lipoedema, weight stability rather than limb volume. Progression over 4.6 years tracked BMI change and waist-to-height-ratio change, both p<0.0001, and not age (Forner-Cordero 2025).
Aquatic therapy in the maintenance phase. Twice weekly for 6 weeks improved oedema, function and quality of life more than the control arm (Ergin 2017, 57 patients).
General movement and activity, dose unspecified. Emerging Twelve prospective studies across 367 participants show small positive effects on quality of life, physical function, pain and limb volume, at high risk of bias throughout. The authors state outright that evidence-based exercise recommendations are not possible, and the review excluded lipoedema entirely (Wittenkamp 2025).
Antibiotic prophylaxis for recurrent cellulitis, a medical decision. Suppressive rather than curative: 23 of 48 patients still recurred on prophylaxis, at 26% by one year and 36% by two, with no predictor of who would fail (Vignes 2006, upper limb). The leg-population evidence is a Cochrane review whose search closed in June 2016 (Dalal 2017).
Every number in this table is a starting point, not a prescription, and it is tagged so you know which is which. No trial in either condition has randomised a single set, repetition, load or frequency. The compression numbers above are different: those come from actual trials. Anyone who gives you a precise exercise dose for this condition is giving you their opinion, which is allowed, but it is not the same thing as evidence.
| Exercise | How | Dose | Frequency | Guide |
|---|---|---|---|---|
| Ankle pumps | Leg supported. Point the toes away, then pull them back. The calf is a pump and this works it | 2 × 20 consensus | 3-4× daily consensus | Should not hurt |
| Walking | Ordinary walking, in the compression garment | 10-30 min consensus | Most days consensus | Heaviness expected, sharp pain is not |
| Heel raises | Hold a support, rise onto the toes, lower slowly | 2 × 10-15 consensus | Daily consensus | Mild effort, no sharp pain |
| Leg elevation | Lying, with the leg above the level of the heart. Not a footstool | 15-20 min consensus | 2-3× daily consensus | Should feel relieving |
| Water-based exercise | Walking or gentle exercise in chest-deep water | 30-45 min | 2× weekly | The one row with trial support (Ergin 2017) |
| Resistance training | Normal whole-body strength work, built up gradually, garment on | Not established by any trial | Not established | Build slowly, wear compression |
Go today, not at your next appointment.
Refer to: GP for systemic causes and antibiotics. Vascular for arterial assessment, duplex and objective lymphatic imaging. Emergency care for suspected clot out of hours, or anyone systemically unwell with cellulitis. A specialist lymphoedema service for garment fitting and staging.
Neither condition is a reason to stop training. There is no evidence that resistance training worsens either, and the general activity evidence points the other way. What changes is the measurement, not the permission.
No set, repetition, load or frequency landmark from general training practice applies here, because none has been tested in this population. Progress on symptoms and on morning limb size, not on a schedule. If the limb is measurably larger the next morning, reduce lower-body volume, increase elevation and garment wear time, hold for a week, then rebuild.
Moderate Endpoint-stratified across 12 claims.
HIGH: lipoedema is not a lymphatic disease in its early stages; sustained compression reduces lower-limb oedema volume.
MODERATE: the 40 to 60 mmHg window; adjustable devices matching bandaging; prophylaxis after pelvic lymphadenectomy; compression preventing cellulitis recurrence; progression tracking fat gain rather than time.
LOW and negative in direction: manual lymphatic drainage adding volume reduction; pneumatic compression adding benefit; clinical signs reliably diagnosing lymphoedema.
LOW: liposuction as an established standard of care.
NO EVIDENCE: any specific exercise prescription. None
Lymphoedema is a transport failure. Protein-rich interstitial fluid outruns lymphatic clearance. The chronic consequence is not fluid but tissue: adipose deposition and fibrosis follow, which is why long-standing lymphoedema stops pitting and why a limb swollen for years does not decongest back to normal.
The commonest route into it is not cancer. In 440 consecutive patients the causes were chronic venous insufficiency, or phlebolymphoedema, at 41.8%, cancer-related lymphoedema at 33.9%, primary lymphoedema at 12.5%, and lipoedema with secondary lymphoedema at 11.8% (Dean 2020). Untreated vein disease is the leading road in, which makes the venous assessment part of the lymphoedema workup rather than an alternative to it.
Lipoedema is a lipodystrophy, and three independent imaging methods across 27 years agree. Harwood 1996 put ten patients through quantitative lymphoscintigraphy: not one reached the impairment seen in true lymphoedema. Rasmussen 2022 imaged twenty women with early-stage disease against controls matched for age and body mass, and found the vessels dilated but propulsion rates significantly exceeding controls, with no dermal backflow. Mackie 2023 imaged forty women by indocyanine green lymphography and found 34 of 40, or 85%, with completely normal lymphatics.
Child 2010's pedigree series places the origin elsewhere again: an inherited condition, most consistent with autosomal dominant inheritance with sex limitation, apparently oestrogen-requiring, manifesting at puberty. Lymphatic failure in lipoedema is a late complication, not the mechanism.
The single most useful clinical question is what the feet are doing. Lymphoedema takes the toes. Lipoedema stops at the ankle in a cuff. Add pressure tenderness and easy bruising and the picture is usually clear without imaging, which matters because objective lymphatic imaging is not available in most settings.
Against objective imaging in 636 swollen limbs, combined clinical signs reached sensitivity 17%, specificity 88% and accuracy 47%. Among 258 limbs with an abnormal scan, only 17% showed any clinical sign at all. A positive sign is worth having. A negative one is uninformative, and it should never be used as an exclusion. Note the population is a vascular referral clinic, which is not primary care.
One line of trials found a straightforward dose-response across 20 to 60 mmHg. Another, testing up to 88 mmHg, found volume reduction decreasing above roughly 60. These are not contradictory findings, they are the same curve read from opposite ends: the first study's ceiling is exactly where the second study's curve turns over. The useful window on a leg is 40 to 60 mmHg sustained.
A three-variable model separating lipoedema from lymphoedema reports 100% accuracy with a probability error of 0.0%. Entry to its lipoedema cohort required meeting at least three of a feature list that already included bruising, symmetry, spared feet and an absent Stemmer sign. The model then selected bruising, disproportion and spared feet. It recovered its own inclusion criteria on the sample those criteria defined, which is not validation. The feature list is clinically useful and is used above. The accuracy figure is an artefact.
A 2026 systematic review calls lipoedema "a distinct, progressive condition requiring early recognition and intervention", which is the premise underneath early surgery. The only prospective natural-history cohort followed 100 patients for a mean 4.6 years and found 62% stable, 28% progressed, 10% improved, with progression tracking body mass and waist-to-height ratio change at p<0.0001 and showing no relationship with age. The lever on progression is weight gain, and no operation delivers weight stability.
The same review awards tumescent liposuction a "Grade 1 recommendation" while stating its own evidence quality as 2 to 3, and its literature search closed in January 2023. The leading consensus statement calling lymph-sparing liposuction "currently the only effective treatment" came from a congress convened on the subject. None of that makes the operation ineffective. It means the strength of the recommendation is running ahead of the evidence supporting it, and the trial that would settle it has not reported.
The best-conducted trials in this field, including the only proper dismantling trial of manual lymphatic drainage, are breast-cancer-related upper-limb studies. A leg sits under a hydrostatic column an arm never experiences, and a computational model of lower-limb interstitial transport argues gravity can drive a positive feedback loop with no upper-limb equivalent. Treat arm-derived null results as hypotheses in the leg, not settled answers.
Every compression trial here reports millilitres or centimetres. In lipoedema the complaint is pain, tenderness and bruising, not size, which is exactly why the registered surgical trial chose leg pain as its primary endpoint. A treatment that removes 20% of limb volume and does not touch pain has succeeded on the published endpoint and failed the person.
The longest compression trial retrieved lasted three weeks. The adjustable device wins in the head-to-head because the patient re-tightens it, which makes it fundamentally an adherence result, and no trial in this evidence base followed adherence beyond a month. Choose the garment the person will actually put on tomorrow morning. Donning difficulty, not pressure class, is the usual point of failure.
Conservative management success rate: not reported anywhere in this evidence base as a percentage. What exists is conservative therapy graded 2A to 2B for reduced pain and swelling in a narrative review, and a natural history in which 62% of lipoedema patients were stable over a mean 4.6 years with no association between maintenance therapy and progression.
Surgical success rate: not available from any controlled comparison. The uncontrolled data is genuinely encouraging. At a mean 12 years after liposuction, improvement in spontaneous pain, pressure sensitivity, oedema, bruising and movement restriction persisted, with no relevant worsening between years 8 and 12, in 60 patients surveyed by post. In the same cohort, 55% had lost a mean 6.2 kg and 43.3% had gained a mean 7.9 kg. In 191 patients twelve months after two-stage lymphatic-sparing ultrasound-assisted liposuction, circumference fell by a mean 6.4 cm with pain and bruising both significantly reduced and no postoperative phlebitis. Neither study has a control group.
The honest truth. The surgical literature for lipoedema is large, consistent, long-term, enthusiastic, and entirely uncontrolled. Every follow-up study surveys people who chose and paid for an operation, which is the population most motivated to report that it worked. None of that makes it wrong. Twelve-year symptom persistence is not nothing, and the operation may well be genuinely effective. It means the honest position today is that nobody knows how it compares against good conservative care, because the trial that asks is registered and has not reported. A person in real pain who has done the conservative work deserves that uncertainty stated plainly rather than resolved for them in either direction.
Go Deeper
Most people with a swollen leg get a label and no plan, or a plan built for the wrong condition. The Verdict breaks down one protocol like this every week, evidence-scored, with the weak parts labelled as weak.
Join The Verdict, freeEvery pain and rehab verdict, evidence-scored: what actually speeds recovery, what to skip, and when to get it checked.
Browse Pain & Rehab verdictsPhysio conditions reviewed against clinical evidence. What works, what doesn't, and what to do — from a practising physiotherapist.
Subscribe freeThe Verdict is built by the same team behind Precision Metrics — a physique and health coaching practice with 300+ clients coached. Dr. Seth Holbrook, DPT and Luke Holbrook lead the coaching.
Book a free consultationConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.